BG108480A - Течен полимерен състав за предотвратяване и лечение на болести на устната кухина - Google Patents

Течен полимерен състав за предотвратяване и лечение на болести на устната кухина Download PDF

Info

Publication number: BG108480A
Authority: BG; Bulgaria
Prior art keywords: therapeutic agent; eudragit; chloride; polymeric material; composition according
Prior art date: 2001-05-25

Application number

BG108480A

Other languages

Bulgarian (bg)

English (en)

Inventor

Giovanna Galli

Gigliola Pacini

Original Assignee

Italmed S.N.C. Di Galli G. & Pacini G

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-25

Filing date

2003-12-19

Publication date

2004-12-30

2003-12-19 Application filed by Italmed S.N.C. Di Galli G. & Pacini G filed Critical Italmed S.N.C. Di Galli G. & Pacini G

2004-12-30 Publication of BG108480A publication Critical patent/BG108480A/bg

Links

239000000203 mixture Substances 0.000 title claims abstract description 44
229920000642 polymer Polymers 0.000 title claims abstract description 25
239000007788 liquid Substances 0.000 title claims abstract description 17
201000010099 disease Diseases 0.000 title claims abstract description 10
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 10
238000011282 treatment Methods 0.000 title claims description 12
210000000214 mouth Anatomy 0.000 title claims description 4
230000002265 prevention Effects 0.000 title claims description 3
239000003814 drug Substances 0.000 claims abstract description 75
229940124597 therapeutic agent Drugs 0.000 claims abstract description 57
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 46
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
239000000463 material Substances 0.000 claims abstract description 21
229920001577 copolymer Polymers 0.000 claims abstract description 9
230000001476 alcoholic effect Effects 0.000 claims abstract description 5
239000000243 solution Substances 0.000 claims description 26
239000003242 anti bacterial agent Substances 0.000 claims description 18
229920003159 Eudragit® RS 100 Polymers 0.000 claims description 17
229920003155 Eudragit® RL 100 Polymers 0.000 claims description 12
229940088710 antibiotic agent Drugs 0.000 claims description 11
NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 claims description 10
229920003151 Eudragit® RL polymer Polymers 0.000 claims description 8
229920003152 Eudragit® RS polymer Polymers 0.000 claims description 8
FSXVSUSRJXIJHB-UHFFFAOYSA-M ethyl prop-2-enoate;methyl 2-methylprop-2-enoate;trimethyl-[2-(2-methylprop-2-enoyloxy)ethyl]azanium;chloride Chemical compound [Cl-].CCOC(=O)C=C.COC(=O)C(C)=C.CC(=C)C(=O)OCC[N+](C)(C)C FSXVSUSRJXIJHB-UHFFFAOYSA-M 0.000 claims description 8
DNKKLDKIFMDAPT-UHFFFAOYSA-N n,n-dimethylmethanamine;2-methylprop-2-enoic acid Chemical compound CN(C)C.CC(=C)C(O)=O.CC(=C)C(O)=O DNKKLDKIFMDAPT-UHFFFAOYSA-N 0.000 claims description 8
239000008213 purified water Substances 0.000 claims description 8
JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 claims description 8
210000004268 dentin Anatomy 0.000 claims description 6
150000003839 salts Chemical class 0.000 claims description 6
239000011698 potassium fluoride Substances 0.000 claims description 5
235000003270 potassium fluoride Nutrition 0.000 claims description 5
LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 claims description 4
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 4
229960004150 aciclovir Drugs 0.000 claims description 4
229920000249 biocompatible polymer Polymers 0.000 claims description 4
229960002798 cetrimide Drugs 0.000 claims description 4
229960002152 chlorhexidine acetate Drugs 0.000 claims description 4
239000002861 polymer material Substances 0.000 claims description 4
239000011592 zinc chloride Substances 0.000 claims description 4
235000005074 zinc chloride Nutrition 0.000 claims description 4
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
239000001110 calcium chloride Substances 0.000 claims description 3
229910001628 calcium chloride Inorganic materials 0.000 claims description 3
159000000007 calcium salts Chemical class 0.000 claims description 3
125000005395 methacrylic acid group Chemical group 0.000 claims description 3
229960005264 piperacillin sodium Drugs 0.000 claims description 3
WCMIIGXFCMNQDS-IDYPWDAWSA-M piperacillin sodium Chemical compound [Na+].O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C([O-])=O)C(C)(C)S[C@@H]21 WCMIIGXFCMNQDS-IDYPWDAWSA-M 0.000 claims description 3
229910001631 strontium chloride Inorganic materials 0.000 claims description 3
CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 2
LIRCDOVJWUGTMW-ZWNOBZJWSA-N Chloramphenicol succinate Chemical compound OC(=O)CCC(=O)OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 LIRCDOVJWUGTMW-ZWNOBZJWSA-N 0.000 claims description 2
208000004898 Herpes Labialis Diseases 0.000 claims description 2
CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 2
206010067152 Oral herpes Diseases 0.000 claims description 2
MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 claims description 2
DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 claims description 2
229960003805 amantadine Drugs 0.000 claims description 2
239000003443 antiviral agent Substances 0.000 claims description 2
229960000686 benzalkonium chloride Drugs 0.000 claims description 2
229960001950 benzethonium chloride Drugs 0.000 claims description 2
UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 claims description 2
CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims description 2
229960001927 cetylpyridinium chloride Drugs 0.000 claims description 2
YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 claims description 2
229960002579 chloramphenicol sodium succinate Drugs 0.000 claims description 2
229960004714 clindamycin palmitate Drugs 0.000 claims description 2
OYSKUZDIHNKWLV-PRUAPSLNSA-N clindamycin palmitate Chemical compound O1[C@H](SC)[C@H](OC(=O)CCCCCCCCCCCCCCC)[C@@H](O)[C@@H](O)[C@H]1[C@@H]([C@H](C)Cl)NC(=O)[C@H]1N(C)C[C@H](CCC)C1 OYSKUZDIHNKWLV-PRUAPSLNSA-N 0.000 claims description 2
239000003975 dentin desensitizing agent Substances 0.000 claims description 2
XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 claims description 2
229910001629 magnesium chloride Inorganic materials 0.000 claims description 2
229940069338 potassium sorbate Drugs 0.000 claims description 2
235000010241 potassium sorbate Nutrition 0.000 claims description 2
239000004302 potassium sorbate Substances 0.000 claims description 2
MCSINKKTEDDPNK-UHFFFAOYSA-N propyl propionate Chemical compound CCCOC(=O)CC MCSINKKTEDDPNK-UHFFFAOYSA-N 0.000 claims description 2
229940033663 thimerosal Drugs 0.000 claims description 2
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 2
HPGGPRDJHPYFRM-UHFFFAOYSA-J tin(iv) chloride Chemical compound Cl[Sn](Cl)(Cl)Cl HPGGPRDJHPYFRM-UHFFFAOYSA-J 0.000 claims description 2
150000003751 zinc Chemical class 0.000 claims description 2
238000000586 desensitisation Methods 0.000 claims 3
229940111685 dibasic potassium phosphate Drugs 0.000 claims 2
ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims 2
239000002904 solvent Substances 0.000 claims 2
JFYHBSCBWSVVQW-UHFFFAOYSA-L [Cl-].[Cl-].[Zn+2].[Sr+2] Chemical compound [Cl-].[Cl-].[Zn+2].[Sr+2] JFYHBSCBWSVVQW-UHFFFAOYSA-L 0.000 claims 1
239000007864 aqueous solution Substances 0.000 claims 1
BSEHISUIPNKWKT-UHFFFAOYSA-L calcium;zinc;dichloride Chemical compound [Cl-].[Cl-].[Ca+2].[Zn+2] BSEHISUIPNKWKT-UHFFFAOYSA-L 0.000 claims 1
230000000149 penetrating effect Effects 0.000 claims 1
230000001902 propagating effect Effects 0.000 claims 1
159000000008 strontium salts Chemical class 0.000 claims 1
239000003795 chemical substances by application Substances 0.000 abstract description 15
208000005888 Periodontal Pocket Diseases 0.000 abstract description 13
238000000034 method Methods 0.000 abstract description 9
208000028169 periodontal disease Diseases 0.000 abstract description 9
239000000853 adhesive Substances 0.000 abstract description 6
206010052428 Wound Diseases 0.000 abstract description 4
208000027418 Wounds and injury Diseases 0.000 abstract description 4
230000000172 allergic effect Effects 0.000 abstract description 3
208000010668 atopic eczema Diseases 0.000 abstract description 3
230000001225 therapeutic effect Effects 0.000 abstract description 3
241000894006 Bacteria Species 0.000 abstract description 2
230000004888 barrier function Effects 0.000 abstract description 2
230000008569 process Effects 0.000 abstract description 2
229920003134 Eudragit® polymer Polymers 0.000 abstract 2
VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 abstract 2
239000012466 permeate Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 description 14
230000003239 periodontal effect Effects 0.000 description 10
WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 6
239000012530 fluid Substances 0.000 description 6
210000001519 tissue Anatomy 0.000 description 6
230000000694 effects Effects 0.000 description 5
230000001105 regulatory effect Effects 0.000 description 5
238000001356 surgical procedure Methods 0.000 description 5
238000002560 therapeutic procedure Methods 0.000 description 5
230000001070 adhesive effect Effects 0.000 description 4
230000001580 bacterial effect Effects 0.000 description 4
230000008901 benefit Effects 0.000 description 4
230000003115 biocidal effect Effects 0.000 description 4
238000011161 development Methods 0.000 description 4
239000000428 dust Substances 0.000 description 4
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
230000000844 anti-bacterial effect Effects 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
238000009792 diffusion process Methods 0.000 description 3
239000000835 fiber Substances 0.000 description 3
208000015181 infectious disease Diseases 0.000 description 3
239000011159 matrix material Substances 0.000 description 3
244000052769 pathogen Species 0.000 description 3
229920006254 polymer film Polymers 0.000 description 3
239000001103 potassium chloride Substances 0.000 description 3
235000011164 potassium chloride Nutrition 0.000 description 3
230000009885 systemic effect Effects 0.000 description 3
230000000699 topical effect Effects 0.000 description 3
229920002307 Dextran Polymers 0.000 description 2
HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
239000013543 active substance Substances 0.000 description 2
238000013459 approach Methods 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
230000002708 enhancing effect Effects 0.000 description 2
239000000499 gel Substances 0.000 description 2
239000007943 implant Substances 0.000 description 2
230000000813 microbial effect Effects 0.000 description 2
238000002156 mixing Methods 0.000 description 2
201000001245 periodontitis Diseases 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
235000018102 proteins Nutrition 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
210000003296 saliva Anatomy 0.000 description 2
229910052712 strontium Inorganic materials 0.000 description 2
CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
238000007910 systemic administration Methods 0.000 description 2
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
210000005239 tubule Anatomy 0.000 description 2
239000011701 zinc Substances 0.000 description 2
229910052725 zinc Inorganic materials 0.000 description 2
WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 1
RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
208000036169 Actinobacillus Infections Diseases 0.000 description 1
208000020795 Actinobacillus infectious disease Diseases 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
241000282472 Canis lupus familiaris Species 0.000 description 1
102000008186 Collagen Human genes 0.000 description 1
108010035532 Collagen Proteins 0.000 description 1
229920003148 Eudragit® E polymer Polymers 0.000 description 1
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
206010018691 Granuloma Diseases 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
208000025157 Oral disease Diseases 0.000 description 1
206010034133 Pathogen resistance Diseases 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
229920000954 Polyglycolide Polymers 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
SMEGJBVQLJJKKX-HOTMZDKISA-N [(2R,3S,4S,5R,6R)-5-acetyloxy-3,4,6-trihydroxyoxan-2-yl]methyl acetate Chemical compound CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)OC(=O)C)O)O SMEGJBVQLJJKKX-HOTMZDKISA-N 0.000 description 1
206010000269 abscess Diseases 0.000 description 1
230000035508 accumulation Effects 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
229940081735 acetylcellulose Drugs 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
229940072056 alginate Drugs 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 1
229920006318 anionic polymer Polymers 0.000 description 1
239000002260 anti-inflammatory agent Substances 0.000 description 1
229940121363 anti-inflammatory agent Drugs 0.000 description 1
230000000845 anti-microbial effect Effects 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
239000000560 biocompatible material Substances 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
ZADPBFCGQRWHPN-UHFFFAOYSA-N boronic acid Chemical compound OBO ZADPBFCGQRWHPN-UHFFFAOYSA-N 0.000 description 1
NEDGUIRITORSKL-UHFFFAOYSA-N butyl 2-methylprop-2-enoate;2-(dimethylamino)ethyl 2-methylprop-2-enoate;methyl 2-methylprop-2-enoate Chemical compound COC(=O)C(C)=C.CCCCOC(=O)C(C)=C.CN(C)CCOC(=O)C(C)=C NEDGUIRITORSKL-UHFFFAOYSA-N 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000002775 capsule Substances 0.000 description 1
229960003669 carbenicillin Drugs 0.000 description 1
RTYJTGSCYUUYAL-YCAHSCEMSA-L carbenicillin disodium Chemical compound [Na+].[Na+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)C(C([O-])=O)C1=CC=CC=C1 RTYJTGSCYUUYAL-YCAHSCEMSA-L 0.000 description 1
-1 carindicine Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
125000002091 cationic group Chemical group 0.000 description 1
229920002301 cellulose acetate Polymers 0.000 description 1
238000000576 coating method Methods 0.000 description 1
229920001436 collagen Polymers 0.000 description 1
229960005188 collagen Drugs 0.000 description 1
238000013270 controlled release Methods 0.000 description 1
238000011443 conventional therapy Methods 0.000 description 1
208000031513 cyst Diseases 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
208000002925 dental caries Diseases 0.000 description 1
239000005548 dental material Substances 0.000 description 1
210000004262 dental pulp cavity Anatomy 0.000 description 1
201000002170 dentin sensitivity Diseases 0.000 description 1
230000008021 deposition Effects 0.000 description 1
230000009266 disease activity Effects 0.000 description 1
230000009977 dual effect Effects 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
239000005038 ethylene vinyl acetate Substances 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
238000000605 extraction Methods 0.000 description 1
238000011049 filling Methods 0.000 description 1
239000006260 foam Substances 0.000 description 1
238000009472 formulation Methods 0.000 description 1
230000006870 function Effects 0.000 description 1
208000007565 gingivitis Diseases 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
230000035876 healing Effects 0.000 description 1
230000036541 health Effects 0.000 description 1
229940014041 hyaluronate Drugs 0.000 description 1
230000009610 hypersensitivity Effects 0.000 description 1
238000011065 in-situ storage Methods 0.000 description 1
230000003993 interaction Effects 0.000 description 1
238000011835 investigation Methods 0.000 description 1
230000002045 lasting effect Effects 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
229960000282 metronidazole Drugs 0.000 description 1
VAOCPAMSLUNLGC-UHFFFAOYSA-N metronidazole Chemical compound CC1=NC=C([N+]([O-])=O)N1CCO VAOCPAMSLUNLGC-UHFFFAOYSA-N 0.000 description 1
230000004048 modification Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
208000030194 mouth disease Diseases 0.000 description 1
239000002324 mouth wash Substances 0.000 description 1
238000012148 non-surgical treatment Methods 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
230000035515 penetration Effects 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
230000035699 permeability Effects 0.000 description 1
239000008194 pharmaceutical composition Substances 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000004014 plasticizer Substances 0.000 description 1
229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
239000004633 polyglycolic acid Substances 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
229910000160 potassium phosphate Inorganic materials 0.000 description 1
235000011009 potassium phosphates Nutrition 0.000 description 1
159000000001 potassium salts Chemical class 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000001556 precipitation Methods 0.000 description 1
125000001453 quaternary ammonium group Chemical group 0.000 description 1
230000009467 reduction Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
241000894007 species Species 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 description 1
239000000126 substance Substances 0.000 description 1
238000004381 surface treatment Methods 0.000 description 1
239000011885 synergistic combination Substances 0.000 description 1
239000003826 tablet Substances 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
238000011200 topical administration Methods 0.000 description 1
229920003169 water-soluble polymer Polymers 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0063—Periodont
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

BG108480A 2001-05-25 2003-12-19 Течен полимерен състав за предотвратяване и лечение на болести на устната кухина BG108480A (bg)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP01112751A EP1262172A1 (en)	2001-05-25	2001-05-25	Liquid polymer composition for prevention and treatment of the oral cavity diseases

Publications (1)

Publication Number	Publication Date
BG108480A true BG108480A (bg)	2004-12-30

Family

ID=8177549

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG108480A BG108480A (bg)	2001-05-25	2003-12-19	Течен полимерен състав за предотвратяване и лечение на болести на устната кухина

Country Status (12)

Country	Link
US (1)	US20040126333A1 (pl)
EP (2)	EP1262172A1 (pl)
AT (1)	ATE533511T1 (pl)
BG (1)	BG108480A (pl)
CZ (1)	CZ20033541A3 (pl)
HR (1)	HRP20031016A2 (pl)
HU (1)	HUP0401308A2 (pl)
PL (1)	PL366903A1 (pl)
RU (1)	RU2301056C2 (pl)
SK (1)	SK15832003A3 (pl)
UA (1)	UA79091C2 (pl)
WO (1)	WO2002098464A2 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102005050654A1 (de) *	2005-10-20	2007-04-26	LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH	Lippenpflaster
CA2635272C (en) *	2006-01-27	2016-11-29	Yale University	Fast acting inhibitor of gastric acid secretion
US8512761B2 (en)	2006-01-27	2013-08-20	Yale University	Fast acting inhibitor of gastric acid secretion
WO2009098531A1 (en) *	2008-02-07	2009-08-13	Italmed S.R.L.	Dental composition for desensitization and disinfection of exposed dentin
ITPI20080025A1 (it) *	2008-03-31	2009-10-01	Italmed S R L	Composizione ad uso odontoiatrico per il trattamento delle perimplantiti
US9504698B2 (en)	2009-10-29	2016-11-29	Warsaw Orthopedic, Inc.	Flowable composition that sets to a substantially non-flowable state
CN103764230A (zh) *	2010-04-21	2014-04-30	迪斯卡斯牙科有限责任公司	同时清洁和美白牙齿的方法
US20150342839A1 (en)	2010-04-21	2015-12-03	Oraceutica LLC	Compositions and methods for whitening teeth
RU2427379C1 (ru)	2010-09-20	2011-08-27	Закрытое акционерное общество "Институт прикладной нанотехнологии"	Состав для профилактики и ухода за диабетической стопой
US8888489B2 (en)	2012-10-23	2014-11-18	Oraceutical Llc	Method of simultaneously cleaning and whitening teeth
US9125911B2 (en)	2013-03-14	2015-09-08	Quadex Pharmaceuticals, Llc	Combined systemic and topical treatment of disordered tissues
US9549930B2 (en)	2013-03-14	2017-01-24	Quadex Pharmaceuticals, Llc	Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9463180B2 (en)	2013-03-14	2016-10-11	Quadex Pharmaceuticals, Llc	Treatment of molluscum contagiosum
US9320580B2 (en)	2013-04-21	2016-04-26	Oraceutical Llc	Hand-held tooth whitening instrument with applicator reservoir for whitening composition and methods of using same
EP3043870B1 (en) *	2013-09-11	2020-03-04	3M Innovative Properties Company	Oral compositions, dental structures and methods of delivering oral compositions
CN105530998B (zh)	2013-09-11	2018-09-21	3M创新有限公司	口腔组合物
CN105997847A (zh) *	2016-06-24	2016-10-12	昆明悟真生物科技有限公司	一种抑菌凝胶
RU2729058C2 (ru) *	2018-08-23	2020-08-04	федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН)	Способ предупреждения развития вторичного кариеса
IT201900018752A1 (it) *	2019-10-14	2021-04-14	Alessandro Tosetti	Composizione a base di olii essenziali ad uso odontoiatrico per il trattamento della periodontite e della mucosite perimplantare
CN111841454B (zh) *	2020-06-19	2022-07-05	山西振东泰盛制药有限公司	注射用氟氯西林钠凝胶微球、制备装置及其制备方法
CN112076221B (zh) *	2020-09-24	2022-02-22	四川天福精细化工有限公司	一种脱敏糊剂及其制备方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1446709A (en) *	1972-07-06	1976-08-18	Nat Patent Dev Corp	Tooth root canal filling composition
US4701320A (en) *	1984-11-29	1987-10-20	Lederle (Japan), Ltd.	Composition stably containing minocycline for treating periodontal diseases
US5160737A (en) *	1988-05-03	1992-11-03	Perio Products Ltd.	Liquid polymer composition, and method of use
DE3822095A1 (de) *	1988-06-30	1990-01-04	Klinge Co Chem Pharm Fab	Neue arzneimittelformulierung sowie verfahren zu deren herstellung
IL97930A (en) *	1991-04-23	1996-06-18	Perio Prod Ltd	Preparations for whitening two controlled release products that contain a super-oxygen compound
DE4125048A1 (de) *	1991-07-29	1993-02-04	Peggy Albrecht	Arzneimittel mit verzoegerter freisetzung zur behandlung von periodontitis
ES2252865T3 (es) *	1997-09-26	2006-05-16	Noven Pharmaceuticals, Inc.	Composiciones bioadhesivas y metodos para la administracion topica de agentes activos.
CN1320046A (zh) *	1999-07-12	2001-10-31	三得利株式会社	局部给药的药用组合物

2001
- 2001-05-25 EP EP01112751A patent/EP1262172A1/en not_active Withdrawn
2002
- 2002-05-24 AT AT02754586T patent/ATE533511T1/de active
- 2002-05-24 UA UA20031210980A patent/UA79091C2/uk unknown
- 2002-05-24 RU RU2003137568/15A patent/RU2301056C2/ru not_active IP Right Cessation
- 2002-05-24 SK SK1583-2003A patent/SK15832003A3/sk not_active Application Discontinuation
- 2002-05-24 EP EP02754586A patent/EP1392364B1/en not_active Expired - Lifetime
- 2002-05-24 PL PL02366903A patent/PL366903A1/pl not_active Application Discontinuation
- 2002-05-24 HR HR20031016A patent/HRP20031016A2/xx not_active Application Discontinuation
- 2002-05-24 CZ CZ20033541A patent/CZ20033541A3/cs unknown
- 2002-05-24 HU HU0401308A patent/HUP0401308A2/hu unknown
- 2002-05-24 WO PCT/EP2002/005728 patent/WO2002098464A2/en not_active Ceased
2003
- 2003-11-25 US US10/722,334 patent/US20040126333A1/en not_active Abandoned
- 2003-12-19 BG BG108480A patent/BG108480A/bg unknown

Also Published As

Publication number	Publication date
ATE533511T1 (de)	2011-12-15
EP1392364A2 (en)	2004-03-03
RU2301056C2 (ru)	2007-06-20
SK15832003A3 (sk)	2004-08-03
US20040126333A1 (en)	2004-07-01
CZ20033541A3 (cs)	2004-05-12
EP1392364B1 (en)	2011-11-16
HUP0401308A2 (hu)	2004-11-29
WO2002098464A3 (en)	2003-03-20
HRP20031016A2 (en)	2005-10-31
WO2002098464A2 (en)	2002-12-12
PL366903A1 (pl)	2005-02-07
EP1262172A1 (en)	2002-12-04
RU2003137568A (ru)	2005-06-10
UA79091C2 (en)	2007-05-25

Publication	Publication Date	Title
RU2301056C2 (ru)	2007-06-20	Жидкая полимерная композиция для предотвращения и лечения заболеваний полости рта
US5438076A (en)	1995-08-01	Liquid polymer composition, and method of use
US5160737A (en)	1992-11-03	Liquid polymer composition, and method of use
JP7438284B2 (ja)	2024-02-26	高張性抗微生物治療用組成物
EP0381446B1 (en)	1994-08-10	Oral antifungal compositions
ES2218264T3 (es)	2004-11-16	Uso de quimioterapicos para el tratamiento topico.
AU716540B2 (en)	2000-02-24	New pharmaceutical composition with anaesthetic effect
EP0140766B1 (en)	1991-04-10	Intra pocket drug delivery devices for treatment of periondontal diseases
EP0569797B1 (en)	1999-09-08	Intraoral device for slow medicament release
US20110044917A1 (en)	2011-02-24	Dental composition for treating peri-implantitis
AT15430U1 (de)	2017-08-15	Dentales Mittel auf Basis von Hyaluronan und Octenidindihydrochlorid
CN1128614C (zh)	2003-11-26	二氯苄醇在制备局部治疗炎症的制剂中的应用和含它的制剂
JP2002128697A (ja)	2002-05-09	口腔治療予防剤
JPH05201878A (ja)	1993-08-10	歯周炎処置用医薬製剤
Sood et al.	2014	Efficacy of biodegradable xanthan-based chlorhexidine gel (Chlosite®) and 0.2% chlorhexidine irrigation following scaling and root planing for the treatment of chronic periodontitis
ES2647125T3 (es)	2017-12-19	Sistema de liberación oral
IT201900018752A1 (it)	2021-04-14	Composizione a base di olii essenziali ad uso odontoiatrico per il trattamento della periodontite e della mucosite perimplantare
RU2240770C1 (ru)	2004-11-27	Способ лечения хронического катарального гингивита
RU2269974C2 (ru)	2006-02-20	Способ лечения пародонтита
ITFI20140116A1 (it)	2015-11-19	Composizione ad uso odontoiatrico per il trattamento delle tasche paradontali
UA125272C2 (uk)	2022-02-09	Засіб у формі гелевої композиції "бензидафлазівердин" з пролонгованою дією для лікування захворювань тканин пародонта
JPH024710A (ja)	1990-01-09	感染根管及び根尖性歯周組織炎治療用製剤
Mythili et al.	0	Non-Surgical Periodontal Therapy--A Fundamental Approach
Shalaby et al.	2015	Dental Polymers: Gingivitis, Periodontitis, and Dry Socket Treatment
JPH0764732B2 (ja)	1995-07-12	歯痛、歯髄炎治療剤